Background: Secondary prevention is an effective treatment for rheumatic heart disease (RHD), but ensuring high adherence to prophylaxis over many years is challenging and requires understanding of local factors.
Introduction
Rheumatic heart disease (RHD) refers to the heart valve damage resulting from acute rheumatic fever (ARF), itself an abnormal autoimmune reaction to Group A Streptococcal (GAS) infection. Whilst RHD is now rare in industrialised settings, it continues to be a major cause of morbidity and mortality in resource-limited settings, where an estimated 33 million people live with RHD. 1 Secondary prevention of RHD aims to prevent disease progression and complications after diagnosis, by preventing further damage from recurrent GAS infections and ARF episodes. The cornerstone of secondary prevention is the delivery of long-term secondary antibiotic prophylaxis (SAP), most commonly intramuscular benzathine penicillin G (BPG), administered every 3-4 weeks for 10 years or longer.
2 Prophylaxis can effectively reduce the progression of RHD and development of complications, and even the regression of disease, particularly in patients with mild valve disease. 3 Other prevention components include the identification and treatment of GAS infections (presenting as sore throat) and ARF episodes (most commonly presenting as fever with sore or swollen joints). 4 An effective secondary prevention programme must include diagnosis of RHD at the earliest possible stage, prompt assessment and treatment of GAS throat infection and ARF, and a programme for delivery of SAP. Echocardiography is highly sensitive for early detection of RHD, 5 and therefore screening using echocardiography is under consideration as a preventative strategy in many countries. 6 In Fiji, young people with RHD diagnosed on echocardiographic screening can develop severe, complicated disease and have worse health outcomes than unaffected young people. 7, 8 Although many patients with RHD do not have a history of ARF, secondary prevention should include health education, including specific advice to seek medical care for symptoms of sore throat or ARF. 9 These awareness messages have been incorporated into RHD screening activities in Fiji, but the health seeking attitudes and behaviours of the population are not well known. The principles of population-based screening suggest an acceptable treatment must be available that can alter the natural history of disease. 10, 11 In the context of RHD prevention, SAP can only be effective if there is high adherence, with 80% of recommended injections received suggested as a minimum threshold. 9 However, the adherence to SAP in Fiji is low, with only 6% of those with screening-detected RHD receiving adequate prophylaxis. 12 Similar challenges with SAP have been documented in many other settings. 13, 14 Adherence is defined by WHO as 'the extent to which … taking medication… corresponds with agreed recommendations from a healthcare provider'. 15 Adherence is an issue for treatment of most chronic diseases, and factors affecting adherence may be classified as relating to socio-economics; the health system and health care team; the therapy; the condition and the patient. 15 In order to develop strategies to improve secondary prevention of RHD, knowledge of specific local factors in each of these domains is required. Therefore, the objectives of this study were to understand the health seeking behaviours and factors affecting adherence to SAP in Fiji, and to identify opportunities and strategies for improving secondary prevention of RHD.
Methods

Study setting
Fiji is a South Pacific nation of 332 islands with a population of approximately 900 000. RHD is a leading cause of mortality in children and young adults. 16 Fiji has conducted sporadic echocardiographic screening for RHD in school-aged-children since 2006, revealing a very high prevalence. 17 Children diagnosed with definite RHD, including on screening, are recommended SAP using intramuscular BPG. The Ministry of Health and Medical Services manages a register-based RHD control programme, operational since 2005. In 2014, a project commenced to strengthen the RHD programme, with particular emphasis on improving SAP, as well as developing a national strategy for screening, health professional training and health promotion. 18 
Study participants
All young people with any form of RHD, diagnosed on echocardiography during previous screening studies in the Central Division of Fiji, from 2006 to 2013, [19] [20] [21] were eligible to participate. This included 'probable' and 'definite' RHD cases, using criteria from the National Institutes for Health and WHO 22 and 'borderline'
and 'definite' RHD cases, using the 2012 World Heart Federation criteria. 23 Research staff contacted eligible families with an invitation to participate and provided verbal and written information regarding study procedures. Signed informed consent was obtained from participants, or from a parent or guardian for those aged less than 18 years. Signed assent was additionally obtained for participants aged 10 years and above.
Interviews
We used a structured interview format, consisting of mainly closed questions with categorical or Likert-response items, and some open-ended questions to provide more detailed information on participant perspectives and suggestions for improvement. Content covered the five dimensions of adherence, 15 based on experiences of the Fiji RHD programme and previous qualitative research. 24 All interviewees were asked questions regarding demographics, disease and treatment details, and health seeking behaviours and experiences. Some participants were not receiving SAP, as they had not been formally diagnosed with RHD or commenced on treatment. Those who had received SAP were asked further questions on attitudes and practice around SAP, and potential strategies for improving adherence. The quality of the SAP injection service from the young person's perspective was assessed using questions from the 'Adolescent client interview tool' in the WHO Quality Assessment Guidebook for Adolescent Clients, 25 adapted to suit the Fiji context. This tool uses a series of questions to assess the equitable, accessible, acceptable, appropriate and effective characteristics of health services. The interview was pretested with six individuals with clinically diagnosed RHD, and refinements made to improve clarity and understanding.
The primary respondent varied based on the age of the young person. Participants aged 18 years and over gave their own answers. Those aged 15 years and under were accompanied by a parent or guardian who was considered the primary respondent, although the young person was encouraged to actively participate. Those aged 15-17 years were encouraged to give their own answers, but given the option of an accompanying parent or guardian answering as the primary respondent.
Interviews were completed from August to November 2015. Interviews were conducted within health clinics and hospitals, in areas free from interruptions, and where privacy could be ensured, and took 20-30 minutes to complete. Participants were reimbursed for travel but no other payments or inducements were made. A Fijian research assistant (MA) conducted the interviews, after receiving specific training. A paediatrician (DE) was present for clarification of clinical or other issues. Interviews were conducted in English, with translation or clarification in Fijian or Hindi dialects if required. Responses were recorded by the interviewer on paper forms. Open-ended responses were transcribed verbatim.
Information on adherence to SAP was manually collected from clinic injection records, as reported elsewhere. 12 Adherence was defined as the proportion of days covered by BPG injections received from December 2011 to December 2014. Data were unavailable for some participants who had been receiving SAP for less than 12 months.
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Statistical analysis
Categorical responses were analysed using descriptive statistics. Likert-items were condensed to positive and negative categories. A score for each of the WHO Quality Assessment characteristics was calculated as the mean of individual question scores, as per the guidebook. 25 Content analysis was used for responses to open-ended questions. After familiarisation with the data, key responses were recorded, then grouped by topic and number of respondents. De-identified data were managed and analysed using Stata version 14 (Stata Corp, College Station, TX, USA).
Ethical approval
The study protocol was approved by the Fiji National Research Ethics Review Committee (2015.17) and the Human Research Ethics Committee of the Royal Children's Hospital, Australia (35059A).
Results
Of 134 eligible participants, 101 (75.4%) were recruited and completed the interview, with the young person as the primary respondent in 74 (73%) ( Table 1) . Only 55 participants were aware of a diagnosis of RHD, of whom 50 were currently being treated with SAP. Adherence was very low, with 35 (70%) participants not protected by SAP for half of the observation days.
Health seeking behaviours
Forty-two participants reported a sore throat in the preceding 12 months, of whom 18 (43%) attended a clinic and 15 (83% of attendees; 36% of those with sore throat) were treated with antibiotics. Of those without a sore throat, 83% (49 of 59) stated they would attend clinic if they experienced a sore throat (Figure 1 ).
Twenty-eight participants reported an episode of fever with sore joints in the preceding 12 months, of whom 18 (64%) attended a clinic, 11 (61%) were referred to hospital or specialist care, 7 (39%) were investigated with blood tests and 4 (22%) with an echocardiogram. Of those without a fever and sore joints, 89% (65 of 73) stated they would attend a clinic if they experienced an episode (Figure 2) .
The most frequent reason for not seeking medical attention for sore throat or fever with sore joints was taking an alternate treatment (including herbal medicines, paracetamol, massage and prayer; Supplementary Table 1) . Respondents also perceived the conditions to be benign and self-limiting, expressed a fear/dislike of medical clinics or workers, or identified practical barriers.
Secondary antibiotic prophylaxis -current practice
Fifty participants had recently received SAP and completed the adherence sections of the interview. Thirty participants (60%) sometimes travelled to clinics other than their local health clinic to receive injections. The main reasons given were medication unavailability and logistic reasons of proximity of the clinic to family, school or employment. The most common reasons for missing injections were lack of understanding that injections were required, feeling well and healthy, transport unavailability and no medication supply at the clinic (>40% of participants each, Table 2 ). A total of 41 (82%) participants reportedly missed injections due to at least one of the factors asked.
Thirty-seven participants (74%) described their first SAP injections as painful, but only 11 (22%) described current injections as painful. Fourteen (28%) responded that pain caused them to miss injections. Secondary prophylaxis cards or booklets that list dates of injections were owned by 39 (78%) and, of these, 31 (79%) stated they used the card most or all of the time, and 36 (92%) described the card as very useful.
Quality of prophylaxis injection service
Assessment of the quality of the injection services, using the WHO Adolescent client tool, revealed high scores for equitable (90%) and accessible (97%) characteristics, with lower scores for acceptable (72%) and effective (80%) characteristics of an adolescent-friendly health service (Table 3) . Questions with the strongest response were that services were provided without charge (50, 100%), that nurses made participants feel comfortable (47, 94%) and opening hours were convenient (47, 94%). 
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Questions with the lowest score were an awareness of adolescents involved in health service decisions and policies for RHD (0%), explanation of referral processes when required (7 of 12, 58%), availability and usefulness of educational materials (63%) and nurses having enough time to answer questions (33, 66%). Altogether, 18% responded the clinic did not have appropriate supplies to treat them.
Suggestions for improving adherence
A reminder to attend clinic for SAP injection was considered helpful or very helpful by 47 (94%) of participants. Access and use of communication technology was highest for mobile phones (41, 82%), then Facebook (a social networking website; www.facebook.com) (37, 74%) and e-mail (22, 44%), although many participants did not access these services daily and some had no access to any (see Supplementary Table 2 ). Mobile phone reminders were perceived to be the most helpful of the proposed strategies (38, 76%), particularly phone calls, but also text messages and utilising device alarms.
Responses on the most convenient time to attend clinic varied, with no predominant response. Several participants nominated times outside of normal clinic hours, including early mornings, late afternoons or weekends, in order to fit around school and work commitments. Most participants expressed a preference to receive injections at a clinic, with only 5 (10%) stating they would prefer school-based injections, despite 12 (24%) indicating it would be more affordable to receive injections at the school.
When asked about additional suggestions to improve the SAP injection service, several participants suggested a flexible administration service model, including receiving injections at school or via a mobile outreach service, training parents to administer injections, or providing assistance to overcome transport barriers. Additional comments included concerns about injection technique from less-experienced nurses, a preference for an oral treatment due to injection pain, and the need for greater explanation about when and how to get injections. Thirty-seven (74%) participants expressed interest in becoming involved in decisions and policies regarding RHD prevention.
Discussion
We report new insights into the health seeking behaviours and factors affecting adherence to RHD prevention, using a structured interview of 101 young people in Fiji. The main findings, presented within the five domains influencing adherence, are shown in Text Box 1.
Sore throat was experienced by >40% of participants. Most did not seek medical care, predominantly because the infection was thought to be benign, self-resolving or adequately managed with alternative treatments. Whilst not all sore throats would be due to GAS infection, that only 36% were treated with antibiotics 
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represents an opportunity for improvement. Fever with sore or swollen joints was experienced by 28% of participants. In this setting, many episodes may be due by self-limiting viral infections, however, young people with a history of RHD are at high risk of ARF recurrence, and should be clinically evaluated to exclude ARF. An important public health and health worker education message is to 'think ARF' for high-risk young people presenting with fevers and sore/swollen joints. 26 For both sore throat and sore joints, the proportion that actually attended clinic was far lower than the proportion that anticipated they would attend if they experienced future symptoms, highlighting the complexity of health seeking decisions and behaviours. Health beliefs in Fiji may not align with biomedical models of disease pathogenesis, and use of traditional or herbal medicine is common. 27 The interviewed cohort had poor adherence overall, and it was not possible to evaluate differences between adherent and non-adherent participants. Many patients missed injections as they felt healthy or did not understand why injections were needed. RHD is a chronic condition, where the link between injections and a healthy heart is not simple to communicate, and where patients often feel well until catastrophic complications occur. This reiterates the need for ongoing health education after diagnosis. The relationship between patient and health worker are critical in chronic disease management, 15, 28, 29 and interventions to strengthen the healthcare experience, incorporating simple health education messages and regular follow-up, preferably by the same worker, should be explored.
Transport availability and costs were the cause of many missed injections, similar to a study from Uganda. 29 In Fiji, healthcare is provided without cost, but transport from villages via trucks, buses and boats is time-consuming and very expensive, limiting access. 30 Strategies to reduce or reimburse transport costs would promote adherence, but may be difficult to resource. The majority of patients travelled to distant clinics for injections, suggestive of a mobile population. Patients attending multiple clinics present logistic challenges for RHD programme monitoring and designing patient reminder strategies. Inadequate supply of BPG at clinics emerged as a major reason for travelling to other clinics and missing injections, and should be a priority area for service improvement. 31 Injections were considered very painful initially, and although perceived pain decreased with length of treatment, it was still a factor for 28% of participants to miss injections. Evidence-based strategies that are known to reduce pain could easily be incorporated into standard practice. 9 Patientheld injection booklets were considered very useful. Similar cards have been reported to be effective in other settings, albeit in uncontrolled and older studies, 32 and further distribution and promotion of their use would be a relatively simple intervention.
Adolescence is the peak period of ARF incidence, and the start of the peak period of RHD prevalence. 33 Therefore, most patients on SAP are older children, adolescents or young adults, which are highly vulnerable age periods for non-adherence. 34 Whilst adolescents transition to adult medical services at age 15 in Fiji, they may lack the neurodevelopmental maturity and executive skills to self-manage a chronic health condition such as RHD. 35 Including family members in management may be important to improving adherence. 34 The BPG injection service received fairly high quality scores overall, yet several young people described their dislike or negative experiences, highlighting the importance of ongoing strengthening of the adolescent-friendly qualities of the health service. In particular, no participants were aware of adolescents involved in RHD policy and decision making, yet there was a very strong desire to become involved. There is a major opportunity to utilise the perspectives of young people with RHD to improve health service acceptability and effectiveness, and to share RHD-related and general health education. The availability and usefulness of educational materials could be strengthened, capitalising on the opportunity of patients waiting for injections.
Almost all participants believed a recall and reminder system would help to improve adherence, consistent with a qualitative study from Australia, 28 and with practice in New Zealand, one of Transactions of the Royal Society of Tropical Medicine and Hygiene the few places to document high SAP adherence. 36 Mobile phone reminder systems would appear to be most helpful in increasing attendance, consistent with available evidence from a Cochrane systematic review, 37 although cost, human resources and maintaining contact details are potential barriers. Facebook and e-mail reminders may benefit the smaller group that use these platforms regularly. Phone-based apps may be useful if smartphone use increases, but are not a current priority in this setting.
Whilst there was no dominant opinion on the most convenient time and location to receive injections, there was an eagerness for flexible delivery, fitting around the busy and varied demands of young people's lives. Flexible strategies such as school-based or mobile administration, 36 after-hours clinic times, and even parentadministration could be considered, although each presents pragmatic challenges of staffing, resourcing and ensuring safety.
The Fiji RHD Control and Prevention program is currently undertaking several activities to improve adherence, consistent with several of these findings. A new sore throat guideline will use a clinical decision rule to guide antibiotic treatment, although prediction of GAS infection based on clinical features is challenging. 38 New guidelines on ARF diagnosis will also be implemented. The programme is working with national pharmaceutical services to predict BPG supply requirements and ensure consistent and timely distribution of stock to clinics. Education programmes have been rolled out to clinic nurses nationally, including disease understanding, injection techniques and improving adherence. A young person living with RHD has been appointed to the national RHD Technical Advisory Committee and adolescent representatives participated in a national workshop aiming to improve secondary prevention. Patient-support groups targeting adolescents have commenced. A community awareness strategy, including social media, will focus on the importance of receiving prophylaxis injections and the potential for sore throat and sore joint episodes to cause major illness. A new web-based, RHD register, accessible by all government health-workers with Internet access, may facilitate adherence improvement through real-time entering of injection data and updating patient information and contacts.
Our study has a number of limitations. First, participants were selected from young people with screening-detected RHD in the Central Division of Fiji. Although the results appear consistent with other studies, the relative importance of various factors may not be generalisable to clinically diagnosed patients, younger or older patients, or those living in other settings. Second, the structured interview methodology was developed based on feasibility and pre-testing. Responses are prone to recall bias. The questions were not validated, although we did use an adolescent tool developed by WHO. A qualitative methodology may have allowed a greater depth of understanding. It was not feasible to combine a qualitative study with this project due to available expertise and time constraints, but a separate focus group study will aim to explore these issues further. Assessment of the health service quality was limited to the adolescent's report, with an emphasis on acceptability characteristics. Perspectives of quality from the healthcare provider, clinic manager or community member were not included due to feasibility. Further research into how the various barriers and facilitators to adherence interact and translate into practice would be helpful, particularly as interventions are implemented. Finally, the cost-effectiveness of proposed intervention strategies is not known, and may be a significant barrier, but intervention costs need to be balanced with costs of poor patient health outcomes, reduced productivity and subsequent health system utilisation. Improving adherence for RHD is likely to improve efficiency in many aspects of the health system and management of other chronic diseases. 15 The strengths of the study include the recruitment rate and sample size, and the focus on understanding the perspective of adolescents.
This study identified many factors influencing the secondary prevention of screening-detected RHD in Fiji. Most factors relate to socio-economics, the health system and health care team, the therapy and the condition, with relatively few due to patient factors. Multifaceted, multidisciplinary interventions are needed to improve adherence, focusing on all domains, not simply patient factors. Young people with RHD and their families require support within the health system to reduce the risk of disease and complications.
